Found 56 Enz. Inhib. hit(s) with all data for entry = 50041008 
Affinity DataIC50: 70nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 210nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 250nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 260nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 540nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 540nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 560nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 620nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 630nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 650nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 650nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 680nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 750nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 2.20E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 2.30E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Affinity DataIC50: 2.40E+3nMAssay Description:Compound was evaluated for the inhibition of platelet aggregation, assessed turbidometrically in citrated human platelet rich plasma (PRP)More data for this Ligand-Target Pair
